Skip to main content

Table 5 Medical students’ opinions on control over data sharing

From: To donate or not to donate? Future healthcare professionals’ opinions on biobanking of human biological material for research purposes

 

Definitely not

n (%)

Rather not

n (%)

I do not know

n (%)

Rather yes

n (%)

Definitely yes

n (%)

Median

(IQR)

P for groups differences

What information would you like to receive before submitting samples to the biobank?

 Type and purpose of the research

  1. Medical students (MS)

1 (0.2)

1 (0.2)

0 (0)

27 (6.5)

387 (93.1)

5 (5–5)

ns

  2. Nursing students (NS)

0 (0)

1 (0.4)

1 (0.4)

7 (3)

229 (96.2)

5 (5–5)

  3. Pharmacy students (PS)

0 (0)

0 (0)

1 (0.5)

8 (3.8)

202 (95.7)

5 (5–5)

 Who conducts research and where

  MS

0 (0)

18 (4.3)

5 (1.2)

87 (20.9)

306(73.6)

5 (4–5)

ns

  NS

0 (0)

5 (2.1)

4 (1.7)

55 (23.1)

174(73.1)

5 (4–5)

  PS

2 (1)

12 (5.7)

3 (1.4)

52 (24.6)

142(67.3)

5 (4–5)

 Who owns the biobank

  MS

3 (0.7)

37 (8.9)

20 (4.8)

120 (28.8)

236 (56.7)

5 (4–5)

1 vs. 2 p < 0.05

  NS

3 (1.3)

28 (11.8)

16 (6.7)

80 (33.6)

111 (46.6)

4 (4–5)

1 vs. 3 p < 0.0001

  PS

3 (1.4)

43 (20.4)

12 (5.7)

64 (30.3)

89 (42.2)

4 (3–5)

 

 How long samples will be stored

  MS

6 (1.4)

25 (6)

14 (3.4)

104 (25)

267 (64.2)

5 (4–5)

1 vs. 3 p < 0.01

  NS

3 (1.3)

18 (7.6)

7 (2.9)

55 (23.1)

155 (65.1)

5 (4–5)

2 vs. 3 p < 0.01

  PS

5 (2.4)

22 (10.4)

7 (3.3)

70 (33.2)

107 (50.7)

5 (4–5)

 

 Where the samples will be stored

  MS

3 (0.7)

51 (12.3)

16 (3.9)

120 (28.8)

226 (54.3)

5 (4–5)

2 vs. 3 p < 0.05

  NS

3 (1.3)

20 (8.4)

11 (4.6)

71 (29.8)

133 (55.9)

5 (4–5)

  PS

7 (3.3)

26 (12.3)

8(3.8)

76 (36)

94 (44.6)

4 (4–5)

 Who will have access to the results

  MS

1 (0.2)

9 (2.2)

0 (0)

67 (16.1)

339 (81.5)

5 (5–5)

ns

  NS

0 (0)

3 (1.3)

1 (0.4)

34 (14.3)

200 (84)

5 (5–5)

  PS

1 (0.5)

8 (3.8)

0 (0)

42 (19.9)

160 (75.8)

5 (5–5)

 Conditions for withdrawing samples and data from the biobank

  MS

0 (0)

11 (2.6)

8 (1.9)

69 (16.6)

328 (78.9)

5 (5–5)

2 vs. 3 p < 0.05

  NS

1 (0.4)

5 (2.1)

3 (1.3)

32 (13.4)

197 (82.8)

5 (5–5)

  PS

3 (1.4)

5 (2.4)

5 (2.4)

44 (20.8)

154 (73)

5 (4–5)

 Penalties for investigators who commit abuses

  MS

4 (0.9)

24 (5.8)

13 (3.1)

101 (24.3)

274 (65.9)

5 (4–5)

ns

  NS

0 (0)

5 (2.1)

8 (3.4)

53 (22.3)

172 (72.3)

5 (4–5)

  PS

1 (0.5)

11 (5.2)

8 (3.8)

35 (16.6)

156 (73.9)

5 (4–5)

  1. The statistically significant results are given in boldface